DLD Asset Management’s Insmed INSM Stock Holding History

DLD Asset Management’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-213,000	Closed	-$6.64M	–	89
2017 Q3	$6.64M	Buy	+213,000	New	+$4.06M	0.65%	27

Other funds holding INSM

AAMU

Amundi Asset Management US Boston, Massachusetts $131B AUM 73.57% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

DLD Asset Management's INSM Position: Q4 2017 in Review

DLD Asset Management sold out of Insmed (INSM) in Q4 2017, closing a stake of 240,600 shares — an estimated $7.51M sold.

DLD Asset Management first reported a position in INSM in Q2 2017 and held it in 2 quarters. The position peaked at $7.51M in Q3 2017. 129 funds tracked by Wall St. Rank hold INSM as of Q4 2017.

DLD Asset Management reported no remaining Insmed position as of Q4 2017 after selling out during the quarter.
DLD Asset Management sold 240,600 Insmed shares in Q4 2017, an estimated $7.51M.
DLD Asset Management first reported a position in Insmed in Q2 2017 and held it in 2 quarters.
DLD Asset Management's Insmed position peaked at $7.51M in Q3 2017.
129 funds tracked by Wall St. Rank held Insmed as of Q4 2017.

Based on DLD Asset Management's 13F filing for Q4 2017, filed 12 Feb 2018.